Hillman Ashley D, Witenko Corey J, Sultan Said M, Gala Gary
Department of Pharmacy, The University of North Carolina Hospitals and Clinics, Chapel Hill, North Carolina.
Pharmacotherapy. 2015 Jan;35(1):112-7. doi: 10.1002/phar.1528. Epub 2015 Jan 23.
Serotonin syndrome is a syndrome identified by a triad of altered mental status, neuromuscular overactivity, and autonomic instability caused by the overstimulation of serotonin in the central nervous system and periphery. Serotonin syndrome may be provoked with the addition or increase in serotonergic agents such as selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, tricyclic antidepressants, and monoamine oxidase inhibitors as well as other agents with serotonergic properties. Some narcotics, including fentanyl and methadone, have these properties and may be associated with the development of serotonin syndrome when used in conjunction with other agents. Currently, there are no identified case reports of narcotics as the sole agent causing serotonin syndrome. This report provides a brief overview of serotonin syndrome, particularly with cases involving administration of narcotics such as fentanyl and methadone. The case described is the first report associated with fentanyl and methadone without the coadministration of other serotonergic agents, and a possible drug interaction with voriconazole is discussed. This raises awareness of using multiple serotonergic narcotics and the potential precipitation of serotonin syndrome.
血清素综合征是一种由中枢神经系统和外周血清素过度刺激引起的综合征,其特征为精神状态改变、神经肌肉过度活动和自主神经功能不稳定三联征。血清素综合征可能因血清素能药物(如选择性5-羟色胺再摄取抑制剂、5-羟色胺去甲肾上腺素再摄取抑制剂、三环类抗抑郁药和单胺氧化酶抑制剂)以及其他具有血清素能特性的药物的添加或增加而诱发。一些麻醉药品,包括芬太尼和美沙酮,具有这些特性,与其他药物合用时可能会引发血清素综合征。目前,尚无麻醉药品作为导致血清素综合征的唯一药物的病例报告。本报告简要概述了血清素综合征,特别是涉及芬太尼和美沙酮等麻醉药品使用的病例。所描述的病例是首例与芬太尼和美沙酮相关且未同时使用其他血清素能药物的报告,并讨论了与伏立康唑可能存在的药物相互作用。这提高了对使用多种血清素能麻醉药品以及血清素综合征潜在诱发因素的认识。